Literature DB >> 21666446

Noninvasive versus invasive ventilation for acute respiratory failure in patients with hematologic malignancies: a 5-year multicenter observational survey.

Giuseppe R Gristina1, Massimo Antonelli, Giorgio Conti, Alessia Ciarlone, Silvia Rogante, Carlotta Rossi, Guido Bertolini.   

Abstract

BACKGROUND: Mortality is high among patients with hematologic malignancies admitted to intensive care units for acute respiratory failure. Early noninvasive mechanical ventilation seems to improve outcomes.
OBJECTIVE: To characterize noninvasive mechanical ventilation use in Italian intensive care units for acute respiratory failure patients with hematologic malignancies and its impact on outcomes vs. invasive mechanical ventilation. DESIGN, SETTING, PARTICIPANTS: Retrospective analysis of observational data prospectively collected in 2002-2006 on 1,302 patients with hematologic malignancies admitted with acute respiratory failure to 158 Italian intensive care units. MEASUREMENTS: Mortality (intensive care unit and hospital) was assessed in patients treated initially with noninvasive mechanical ventilation vs. invasive mechanical ventilation and in those treated with invasive mechanical ventilation ab initio vs. after noninvasive mechanical ventilation failure. Findings were adjusted for propensity scores reflecting the probability of initial treatment with noninvasive mechanical ventilation.
RESULTS: Few patients (21%) initially received noninvasive mechanical ventilation; 46% of these later required invasive mechanical ventilation. Better outcomes were associated with successful noninvasive mechanical ventilation (vs. invasive mechanical ventilation ab initio and vs. invasive mechanical ventilation after noninvasive mechanical ventilation failure), particularly in patients with acute lung injury/adult respiratory distress syndrome (mortality: 42% vs. 69% and 77%, respectively). Delayed vs. immediate invasive mechanical ventilation was associated with slightly but not significantly higher hospital mortality (65% vs. 58%, p=.12). After propensity-score adjustment, noninvasive mechanical ventilation was associated with significantly lower mortality than invasive mechanical ventilation. LIMITATIONS: The population could not be stratified according to specific hematologic diagnoses. Furthermore, the study was observational, and treatment groups may have included unaccounted for differences in covariates although the risk of this bias was minimized with propensity score regression adjustment.
CONCLUSIONS: In patients with hematologic malignancies, acute respiratory failure should probably be managed initially with noninvasive mechanical ventilation. Further study is needed to determine whether immediate invasive mechanical ventilation might offer some benefits for those with acute lung injury/adult respiratory distress syndrome.

Entities:  

Mesh:

Year:  2011        PMID: 21666446     DOI: 10.1097/CCM.0b013e3182227a27

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  58 in total

1.  Noninvasive respiratory support for acute respiratory failure-high flow nasal cannula oxygen or non-invasive ventilation?

Authors:  Gerard F Curley; John G Laffy; Haibo Zhang; Arthur S Slutsky
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

2.  [Intensive care management of hematological and oncological patients].

Authors:  M von Bergwelt-Baildon; A Shimabukuro-Vornhagen; M Hallek; M Kochanek
Journal:  Internist (Berl)       Date:  2013-09       Impact factor: 0.743

3.  New puzzles for the use of non-invasive ventilation for immunosuppressed patients.

Authors:  Carmen Sílvia Valente Barbas; Ary Serpa Neto
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

4.  [Hematopoietic stem cell transplantation: bone marrow and blood stem cells].

Authors:  M von Bergwelt-Baildon; U Holtick; M J Hallek; C Scheid
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

5.  Failure of high-flow nasal cannula therapy may delay intubation and increase mortality.

Authors:  Byung Ju Kang; Younsuck Koh; Chae-Man Lim; Jin Won Huh; Seunghee Baek; Myongja Han; Hyun-Suk Seo; Hee Jung Suh; Ga Jin Seo; Eun Young Kim; Sang-Bum Hong
Journal:  Intensive Care Med       Date:  2015-02-18       Impact factor: 17.440

Review 6.  The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Authors:  Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares
Journal:  Intensive Care Med       Date:  2017-07-19       Impact factor: 17.440

7.  Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center.

Authors:  K J Price; M Cardenas-Turanzas; H Lin; L Roden; R Nigam; J L Nates
Journal:  Minerva Anestesiol       Date:  2012-10-02       Impact factor: 3.051

Review 8.  Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.

Authors:  Bram Rochwerg; Laurent Brochard; Mark W Elliott; Dean Hess; Nicholas S Hill; Stefano Nava; Paolo Navalesi; Massimo Antonelli; Jan Brozek; Giorgio Conti; Miquel Ferrer; Kalpalatha Guntupalli; Samir Jaber; Sean Keenan; Jordi Mancebo; Sangeeta Mehta; Suhail Raoof
Journal:  Eur Respir J       Date:  2017-08-31       Impact factor: 16.671

9.  Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study.

Authors:  S G Oeyen; D D Benoit; L Annemans; P O Depuydt; S J Van Belle; R I Troisi; L A Noens; P Pattyn; J M Decruyenaere
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

10.  Management of Acute Respiratory Failure in Patients With Hematological Malignancy.

Authors:  Rakesh Vadde; Stephen M Pastores
Journal:  J Intensive Care Med       Date:  2016-07-07       Impact factor: 3.510

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.